Evidence map›Paper›PMID 40096831›Full record

ArticleCerebrovascular diseases extra2025

Automated Identification of Stroke Thrombolysis Contraindications from Synthetic Clinical Notes: A Proof-of-Concept Study.

Bing Yu Chen, Fares Antaki, Marco Gonzalez, Ken Uchino, Samer Albahra, Scott Robertson, Sidonie Ibrikji, Eric Aube, Andrew Russman, Muhammad Shazam Hussain

Abstract read
In one paragraph

Article in Cerebrovascular diseases extra, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Bing Yu ChenNeurological Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Fares AntakiCole Eye Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Marco GonzalezNeurological Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Ken UchinoNeurological Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Samer AlbahraPathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Scott RobertsonPathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Sidonie IbrikjiNeurological Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Eric AubeNeurological Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Andrew RussmanNeurological Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Muhammad Shazam HussainNeurological Institute, Cleveland Clinic, Cleveland, Ohio, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionTimely thrombolytic therapy improves outcomes in acute ischemic stroke. Manual chart review to screen for thrombolysis contraindications may be time-consuming and prone to errors. We developed and tested a large language model (LLM)-based tool to identify thrombolysis contraindications from clinical notes using synthetic data in a proof-of-concept study.

methodsWe generated 150 synthetic clinical notes containing randomly assigned thrombolysis contraindications using LLMs. We then used Llama 3.1 405B with a custom prompt to generate a list of thrombolysis contraindications from each note. Performance was evaluated using sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), accuracy, and F1 score.

resultsA total of 150 synthetic notes were generated using five different models: ChatGPT-4o, Llama 3.1 405B, Llama 3.1 70B, ChatGPT-4o mini, and Gemini 1.5 Flash. On average, each note contained 241.6 words (SD 110.7; range 80-549) and included 1.5 contraindications (SD 1.1; range 0-5). Our tool achieved a sensitivity of 90.9% (95% CI: 86.3%-94.3%), specificity of 99.2% (95% CI: 98.8%-99.5%), PPV of 87.7% (95% CI: 82.7%-91.7%), NPV of 99.4% (95% CI: 99.1%-99.6%), accuracy of 98.7% (95% CI: 98.2%-99.0%), and an F1 score of 0.892. Among the false positives, 24 (86%) were due to the inclusion of irrelevant contraindications, and 4 (14%) resulted from repetitive information. No hallucinations were observed.

conclusionOur LLM-based tool may identify stroke thrombolysis contraindications from synthetic clinical notes with high sensitivity and PPV. Future studies will validate its performance using real EMR data and integrate it into acute stroke workflows to facilitate faster and safer thrombolysis decision-making.

Indexed as

Decision Support TechniquesElectronic Health RecordsFibrinolytic AgentsIschemic StrokeNatural Language ProcessingStrokeThrombolytic TherapyAutomationContraindications, DrugHumansPredictive Value of TestsProof of Concept StudyReproducibility of ResultsTreatment OutcomeFibrinolytic AgentsAcute ischemic strokeArtificial intelligenceClinical decision supportLarge language modelProof-of-conceptStroke thrombolysis

Identifiers

PMID40096831
PMCPMC12021381

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.